DA
REPL icon

Denali Advisors’s Replimune Group REPL Stock Holding History

Denali Advisors’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-36,300
Closed -$297K – 401
2024
Q1 		$297K Buy
+36,300
New +$298K 0.09% 189

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Denali Advisors's REPL Position: Q2 2024 in Review

Denali Advisors sold out of Replimune Group (REPL) in Q2 2024, closing a stake of 36,300 shares — an estimated $297K sold.

Denali Advisors first reported a position in REPL in Q1 2024 and held it in 1 quarter. The position peaked at $297K in Q1 2024. 149 funds tracked by Wall St. Rank hold REPL as of Q2 2024.

  • Denali Advisors reported no remaining Replimune Group position as of Q2 2024 after selling out during the quarter.
  • Denali Advisors sold 36,300 Replimune Group shares in Q2 2024, an estimated $297K.
  • Denali Advisors first reported a position in Replimune Group in Q1 2024 and held it in 1 quarter.
  • Denali Advisors's Replimune Group position peaked at $297K in Q1 2024.
  • 149 funds tracked by Wall St. Rank held Replimune Group as of Q2 2024.

Based on Denali Advisors's 13F filing for Q2 2024, filed 9 Aug 2024.